Rockefeller University researchers reveal Huntington's neurons are much larger than healthy cells.
UCL researchers report clinical trials of IONIS-HTTRx have shown success in reducing the huntinting protein in the nervous system of those with Huntington's disease. The drug is safe and well tolerated by human patients, the researchers note.
Findings may explain how neurodegenerative diseases spread throughout the brain and disrupt normal functions. Additionally, treatment for one disease could possibly work for the other two also.
Researchers discover a link between neural tube defects and neurodegenerative diseases.
Researchers report Huntington's disease is not only a neurodegenerative disease, it is also a disease that affects muscle tissues.
Researchers have identified a novel type of cell death associated with Huntington's disease.
Researchers have identified several new biological markers to measure the progression of the inherited neurodegenerative disorder Huntington's disease.